Using a well-established model of synucleinopathy [113], two additional studies showed that LRRK2 influences formation of aSyn aggregates both in vitro and in vivo, and that the G2019S mutation increases sensitivity towards pathology and accelerates the progression of aSyn inclusion formation. The gene discussed is LRRK2; the disease is synucleinopathy.